Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02849587 · ClinicalTrials.gov registry record · Phase 1
The Impact and Detection of Driving Impairments Associated With Acute Cannabis Smoking
A Phase 1 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 1
- Development phase
- 199
- Enrollment target
NCT02849587 is a Phase 1 study that has completed, run by University of California, San Diego. The registered enrollment target is 199 participants.
The verdict
NCT02849587, a Phase 1 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 199 participants
- Enrollment target
Study Summary
This study was authorized by the California Legislature (Assembly Bill 266, the Medical Marijuana Regulation and Safety Act to help with detection of driving under the influence of cannabis. One hundred and eighty healthy volunteers will inhale smoked cannabis with either 0% (placebo), 5.9%, or 13.4% Δ9-tetrahydrocannabinol (THC) at the beginning of the day, and then complete driving simulations, iPad-based performance assessments, and bodily fluid draws (e.g., blood, saliva, breath) before the cannabis smoking and a number of times over the subsequent 6 hours after cannabis smoking. The purpose is to determine (1) the relationship of the dose of Δ9-THC on driving performance and (2) the duration of driving impairment in terms of hours from initial use, (3) if saliva or expired air can serve as a useful substitute for blood sampling of Δ9-THC, and (4) if testing using an iPad can serve as a useful adjunct to the standardized field sobriety test in identifying acute impairment from cannabis.
Interventions
- DRUG Cannabis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2017-02-24 |
| Est. Completion | 2019-06-17 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02849587
The ClinicalTrials.gov registry entry for NCT02849587 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 199 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cannabis is the first listed.
NCT02849587 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02849587 about?
NCT02849587 is a clinical study titled "The Impact and Detection of Driving Impairments Associated With Acute Cannabis Smoking". This study was authorized by the California Legislature (Assembly Bill 266, the Medical Marijuana Regulation and Safety Act to help with detection of driving under the influence of cannabis. One hundred and eighty healthy volunteers will inhale smoked cannabis with either 0% (placebo), 5.9%, or 13.4...
What is the current status of trial NCT02849587?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 199 participants. The study started on 2017-02-24. Estimated completion is 2019-06-17.
What interventions are being tested in trial NCT02849587?
The interventions under investigation include: Cannabis (DRUG).
Who is sponsoring clinical trial NCT02849587?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.